615 N. Wolfe Street
Baltimore, Maryland 21205
MD, Harvard Medical School, 1996
Dr. Sharfstein oversees the Office of Public Health Practice and Training, the General Preventive Medicine Residency and major practice activities, including collaboration with public health agencies. He also holds a faculty appointment in the Department of Health Policy and Management. Previously, he served as the Secretary of the Maryland Department of Health and Mental Hygiene, the Principal Deputy Commissioner of the U.S. Food and Drug Administration, as Commissioner of Health for Baltimore City, and as health policy advisor for Congressman Henry A. Waxman.
Circle of Commendation Award, Consumer Product Safety Commission
Public Official of the Year, Governing Magazine
Alpha Omega Alpha, Boston University School of Medicine
Rose Seegal Award for Research, Community Service Award, Robert H. Ebert Prize in Primary Care, Harvard Medical School
Jay S. Drotman Memorial Award, American Public Health Association
Phi Beta Kappa, Thomas Temple Hoopes Prize, Frederick Sheldon Traveling Fellowship, Harvard College
I have written on a wide range of public health topics. Here are a few examples.
Sharfstein J. The strange career of population health. Milbank Quarterly 2014; 92: 640-643.
Rajkumar R, Patel A, Murphy K, Colmers JM, Blum JD, Conway PH, Sharfstein JM. Maryland's All-Payer Approach to Delivery-System Reform. New England Journal of Medicine 2014; 370(6) 493-5.
Olsen Y, Sharfstein J. Confronting the stigma of opioid use disorder—and its treatment. Journal of the American Medical Association 2014; 311: 1393-4.
Sharfstein JM. The FDA--a misunderstood agency. Journal of the American Medical Association 2011; 306:1250-1.
Sharfstein J and Sharfstein SS. Campaign contributions from the American Medical Political Action Committee to members of Congress: For or against the public health? New England Journal of Medicine.1994; 330: 32–37. Correction: 332:1450.